Clinical trial
Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma
NCT00323206 · H. Lee Moffitt Cancer Center and Research Institute, Other · Completed
Key facts
| NCT number | NCT00323206 |
|---|---|
| Title | Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma |
| Official title | Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma |
| Lead sponsor | H. Lee Moffitt Cancer Center and Research Institute, Other |
| Collaborators | National Gene Vector Laboratory |
| Status | Completed |
| Study type | Interventional |
| Conditions | Malignant Melanoma |
| Intervention type | Biological, Procedure |
| Interventions | IL-12p DNA, Intratumoral Electroporation |
| Enrollment | 24 |
| Start date | Jun 1, 2004 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | May 9, 2006 |
| Last update posted | Feb 23, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: